WO2014151573A1 - Method for detecting amyloid beta plaques and drusen - Google Patents

Method for detecting amyloid beta plaques and drusen Download PDF

Info

Publication number
WO2014151573A1
WO2014151573A1 PCT/US2014/026023 US2014026023W WO2014151573A1 WO 2014151573 A1 WO2014151573 A1 WO 2014151573A1 US 2014026023 W US2014026023 W US 2014026023W WO 2014151573 A1 WO2014151573 A1 WO 2014151573A1
Authority
WO
WIPO (PCT)
Prior art keywords
drusen
amyloid beta
beta plaques
super
pathology
Prior art date
Application number
PCT/US2014/026023
Other languages
French (fr)
Inventor
Steven Verdooner
David Biggs
Austin BLANCO
Original Assignee
Steven Verdooner
David Biggs
Blanco Austin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Steven Verdooner, David Biggs, Blanco Austin filed Critical Steven Verdooner
Priority to JP2016502029A priority Critical patent/JP2016512712A/en
Priority to EP14768715.6A priority patent/EP2967327A4/en
Publication of WO2014151573A1 publication Critical patent/WO2014151573A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B3/00Apparatus for testing the eyes; Instruments for examining the eyes
    • A61B3/10Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions
    • A61B3/102Objective types, i.e. instruments for examining the eyes independent of the patients' perceptions or reactions for optical coherence tomography [OCT]
    • GPHYSICS
    • G06COMPUTING; CALCULATING OR COUNTING
    • G06TIMAGE DATA PROCESSING OR GENERATION, IN GENERAL
    • G06T7/00Image analysis
    • G06T7/0002Inspection of images, e.g. flaw detection
    • G06T7/0012Biomedical image inspection

Definitions

  • the present invention is a method for detecting. More specifically, the present invention is a method for detecting amyloid beta plaques and drusen.
  • Optical coherence tomography or OCT is also an imaging technique that is utilized whereby retinal structures may be viewed in cross-section. Relatively larger drusen are visible in OCT images as elevations of retinal pigment epithelium or RPE.
  • the utilization of infrared imaging is much more comfortable and advantageous in elderly patients with lens opacities, since light is scattered relatively much less in the presence of media opacities.
  • l confocal scanning laser ophthalmoscope or SLO is utilized to image the retina with an infrared laser. It is based on indirect mode imaging of a SLO.
  • the present invention is a method for detecting. More specifically, the present invention is a method for detecting amyloid beta plaques and drusen.
  • the method for detecting amyloid beta plaques and drusen may include means for imaging a plurality of frames of multiple views of a central portion and a peripheral portion of the patient user's retina, means for aligning and combining the frames utilizing one or more super-resolution techniques, means for monitoring the aligned and combined frames and means for quantifying changes in the monitored, aligned and combined frames.
  • the method for detecting amyloid beta plaques and drusen may include the steps of utilizing an annual aperture with a central stop that deviates laterally from a confocal light path, blocking directly reflected light from a fundus with only laterally scattered light passing through the annular aperture, thereby imaging the one or more amyloid beta plaques and drusen, identifying the imaged one or more amyloid beta plaques and drusen in a retinal structure and a pathology, applying a combination of optical retro mode illumination techniques to the imaged one or more amyloid beta plaques and drusen and detecting the imaged one or more amyloid beta plaques and drusen that are too small to be seen with other imaging modalities.
  • a non-transitory computer storage media having instructions stored thereon which, when executed, execute a method for detecting amyloid beta plaques and drusen may include the steps of utilizing an annual aperture with a central stop that deviates laterally from a confocal light path, blocking directly reflected light from a fundus with only laterally scattered light passing through the annular aperture, thereby imaging the one or more amyloid beta plaques and drusen, identifying the imaged one or more amyloid beta plaques and drusen in a retinal structure and a pathology, applying a combination of optical retro mode illumination techniques to the imaged one or more amyloid beta plaques and drusen and detecting the imaged one or more amyloid beta plaques and drusen that are too small to be seen with other imaging modalities.
  • FIG. 1 illustrates a flowchart of a first method for detecting amyloid beta plaques and drusen, in accordance with one embodiment of the present invention.
  • FIG. 2 illustrates a flowchart of a second method for detecting amyloid beta plaques and drusen, in accordance with one embodiment of the present invention.
  • FIG. 3 illustrates a flowchart of a method for detecting amyloid beta plaques and drusen by a non-transitory computer storage media having instructions stored thereon which, when executed, execute the method, in accordance with one embodiment of the present invention.
  • FIG. 1 illustrates a flowchart of a first method 1 00 for detecting amyloid beta plaques and drusen, in accordance with one embodiment of the present invention.
  • the overall first method 100 may include means for imaging a plurality of frames of multiple views of a central portion and a peripheral portion of the patient user's retina 1 10, means for aligning and combining the frames utilizing one or more super-resolution techniques 120, means for monitoring the aligned and combined frames 130 and means for quantifying changes in the monitored, aligned and combined frames 140.
  • the means for imaging 1 10 may utilize an optical coherence tomography or OCT imaging technique that is utilized whereby retinal structures may be viewed in cross-section.
  • the means for aligning and combining 120 may utilize a combination of optical retro mode illumination techniques utilizing a confocal laser scanning ophthalmoscope and one or more super-resolution image processing techniques.
  • the means for monitoring the aligned and combined frames 130 may be performed by a non-transitory storage media that receives the retinal structures viewed in cross-section from the optical coherence tomography imaging technique and confocal laser scanning ophthalmoscope and one or more super-resolution image processing techniques.
  • the non-transitory storage media may be executed by a processor and a memory system.
  • the means for quantifying 140 may also be performed by the non-transitory storage media.
  • FIG. 2 illustrates a flowchart of a second method 200 for detecting amyloid beta plaques and drusen, in accordance with one embodiment of the present invention.
  • the second method 200 may include the steps of utilizing an annual aperture with a central stop that deviates laterally from a confocal light path 210, blocking directly reflected light from a fundus with only laterally scattered light passing through the annular aperture, thereby imaging the one or more amyloid beta plaques and drusen 220, identifying the imaged one or more amyloid beta plaques and drusen in a retinal structure and a pathology 230, applying a combination of optical retro mode illumination techniques to the imaged one or more amyloid beta plaques and drusen 240 and detecting the imaged one or more amyloid beta plaques and drusen that are too small to be seen with other imaging modalities 250.
  • the utilizing step 210 may include utilizing an optical coherence
  • the blocking step 220 may include utilizing an optical coherence tomography or OCT imaging technique that is utilized whereby retinal structures may be viewed in cross-section.
  • the identifying step 230 may include the pathology that is Alzheimer's disease or the pathology that is dry macular degeneration.
  • the applying step 240 may include the optical retro mode illumination techniques that may include a confocal laser scanning
  • the detecting step 250 may include tracking changes in the pathology over a predetermined period time.
  • the tracking changes may include plaque, size, area and density over the
  • FIG. 3 illustrates a flowchart of a method 300 for detecting amyloid beta plaques and drusen by a non-transitory computer storage media having instructions stored thereon which, when executed, execute the method 300, in accordance with one embodiment of the present invention.
  • the non-transitory computer storage media may include the steps of utilizing an annual aperture with a central stop that deviates laterally from a confocal light path 310, blocking directly reflected light from a fundus with only laterally scattered light passing through the annular aperture, thereby imaging the one or more amyloid beta plaques and drusen 320, identifying the imaged one or more amyloid beta plaques and drusen in a retinal structure and a pathology 330, applying a combination of optical retro mode illumination techniques to the imaged one or more amyloid beta plaques and drusen 340 and detecting the imaged one or more amyloid beta plaques and drusen that are too small to be seen with other imaging modalities 350.
  • the utilizing step 310 may include utilizing an optical coherence
  • the blocking step 320 may include utilizing an optical coherence tomography or OCT imaging technique that is utilized whereby retinal structures may be viewed in cross-section.
  • the identifying step 330 may include the pathology that is Alzheimer's disease or the pathology that is dry macular degeneration.
  • the applying step 340 may include the optical retro mode illumination techniques that may include a confocal laser scanning
  • the detecting step 350 may include tracking changes in the pathology over a predetermined period time.
  • the tracking changes may include plaque, size, area and density over the
  • the method for detecting amyloid beta plaques and drusen may utilize an annular aperture with a central stop that deviates laterally from a confocal light path. Directly reflected light emitted towards a fundus may be blocked by a central stop with only scattered light passing through the annular aperture. Laterally scattered light may be sampled more than light in a direct mode. Retinal structures and pathology may be detected with the only laterally scattered light. Drusen and AB plaques may be imaged with this technique due to increase in scatter. While the method may be helpful in detection of large plaques, the combination of the method with super-resolution and other image processing and analysis techniques may yield a method that may detect relatively much smaller plaques at relatively earlier stages of pathology and may also be tracked over time.
  • Amyloid beta plaque and drusen may be identified in a retinal structure however identification of the deposits at relatively earlier stages of disease and of a relatively small size is impossible with existing retinal imaging technology. This problem may be solved through a combination of optical retro mode illumination techniques utilizing a confocal laser scanning ophthalmoscope in combination with super-resolution image processing techniques that detect relatively very small plaques that are too small to be seen with other imaging modalities. Utilizing retro mode imaging alone does yield some imaging of drusen, AB plaques and other deposits that are relatively small in size but do not reliably image relatively small to very small plaques.
  • Multi-image super-resolution techniques may record a series of images and then combine a data set from the series of images to produce images of relatively greatly improved resolution and image quality thereby resolving the relatively smallest plaques at the relatively earliest stages of disease. Furthermore, tracking changes in plaque, size, area and density over a predetermined period of time is likely an indicator of advancing disease and rate of advancing disease. These aspects have never been previously studied. Multiple images may be acquired utilizing each of the retro-mode
  • illumination techniques These images may be transferred to a software or non- transitory storage media to co-registers each of the images.
  • the non-transitory storage media may process the images to increase contrast where intensity shifts occur.
  • the non-transitory storage media may increase a signal by subtracting noise.
  • the subtracted noise may be accomplished by referencing numerous modal images and producing a result where the noise or artifact error from each type of retro mode is removed leaving only the combined signal structures from each retro mode image.
  • the resulting super resolution image may be relatively highly improved over each individual retro mode image and by reducing the signal and building the noise in the individual retro mode image, higher detection sensitivity may be achieved in the final image.
  • a high bit depth final image of approximately eight bits or more may be produced which may be analyzed utilizing conventional methods.
  • fluorescent emission images may be combined with retro-mode images to produce a co-located detection matrix.
  • standard confocal infrared or IR images may be combined with retro-mode images to produce a higher sensitivity traditional confocal image or to produce a hyper-contrast combination image.
  • an annual aperture utilized in the retromode may be replaced with a slit, grid, holographic interference image or coded aperture to further increase detection of traditionally sub-resolvable spots.
  • multiple focal planes may be acquired and combined, to produce a three-dimensional render of the detected spots.
  • the aperture position may be stepped in the optical path, to alter its interaction with the reflected or emitted light from a subject.
  • the method may be utilized for a variety of imaging procedures including color fundus imaging, fluorescein angiography, I ndocyanine Green or ICG angiography, red-free, infrared or IR retro-illumination, hyper spectral and multi-spectral imaging, and devices that are utilized in combination with OCT.
  • amyloid beta plaques and drusen will be utilized for the detection and advancement of dry macular degeneration and
  • the method includes imaging a plurality of frames of multiple views of a central portion and a peripheral portion of a patient user's retina, aligning and combining the frames utilizing one or more super-resolution techniques, monitoring the aligned and combined frames and quantifying changes in the monitored, aligned and combined frames.
  • the changes in the aligned and combined frames may be tracked over a predetermined period of time such as a day, a week, a month, a year or other suitable predetermined period of time.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Quality & Reliability (AREA)
  • General Physics & Mathematics (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Theoretical Computer Science (AREA)
  • Eye Examination Apparatus (AREA)

Abstract

A method for detecting amyloid beta plaques and drusen is disclosed. The method for detecting amyloid beta plaques and drusen may include applying a combination of optical retro mode illumination techniques to acquire a plurality of amyloid beta plaques and drusen images that are too small to be seen with other imaging modalities. The amyloid beta plaques and drusen images may also be detected with a non-transitory computer storage media having instructions stored thereon which, when executed, execute the method for detecting amyloid beta plaques and drusen. The method may track changes in plaque, size, area and density of the amyloid beta plaques and drusen over a predetermined period of time.

Description

METHOD FOR DETECTING AMYLOID BETA PLAQUES AND DRUSEN
This application claims priority to U.S. Provisional Application
61 /800,882 filed on 03/15/2013, the entire disclosure of which is incorporated by reference.
BACKGROUND OF THE INVENTION FIELD OF THE INVENTION:
The present invention is a method for detecting. More specifically, the present invention is a method for detecting amyloid beta plaques and drusen.
DESCRIPTION OF THE RELATED ART:
Drusen are early fundus changes characteristic of age-related
maculopathy. Early detection of maculopathy and also Alzheimer's disease with amyloid beta or AB plaques is vitally important to early intervention and treatment. Conventional fundus photography is widely utilized in imaging and detecting drusen. There currently is no method for AB plaque detection except with the utilization of specialized dye and other contrast agents.
Optical coherence tomography or OCT is also an imaging technique that is utilized whereby retinal structures may be viewed in cross-section. Relatively larger drusen are visible in OCT images as elevations of retinal pigment epithelium or RPE. The utilization of infrared imaging is much more comfortable and advantageous in elderly patients with lens opacities, since light is scattered relatively much less in the presence of media opacities. Retro-mode imaging in a
l confocal scanning laser ophthalmoscope or SLO is utilized to image the retina with an infrared laser. It is based on indirect mode imaging of a SLO.
BRIEF SUMMARY OF THE INVENTION
The present invention is a method for detecting. More specifically, the present invention is a method for detecting amyloid beta plaques and drusen.
The method for detecting amyloid beta plaques and drusen may include means for imaging a plurality of frames of multiple views of a central portion and a peripheral portion of the patient user's retina, means for aligning and combining the frames utilizing one or more super-resolution techniques, means for monitoring the aligned and combined frames and means for quantifying changes in the monitored, aligned and combined frames.
The method for detecting amyloid beta plaques and drusen may include the steps of utilizing an annual aperture with a central stop that deviates laterally from a confocal light path, blocking directly reflected light from a fundus with only laterally scattered light passing through the annular aperture, thereby imaging the one or more amyloid beta plaques and drusen, identifying the imaged one or more amyloid beta plaques and drusen in a retinal structure and a pathology, applying a combination of optical retro mode illumination techniques to the imaged one or more amyloid beta plaques and drusen and detecting the imaged one or more amyloid beta plaques and drusen that are too small to be seen with other imaging modalities.
A non-transitory computer storage media having instructions stored thereon which, when executed, execute a method for detecting amyloid beta plaques and drusen may include the steps of utilizing an annual aperture with a central stop that deviates laterally from a confocal light path, blocking directly reflected light from a fundus with only laterally scattered light passing through the annular aperture, thereby imaging the one or more amyloid beta plaques and drusen, identifying the imaged one or more amyloid beta plaques and drusen in a retinal structure and a pathology, applying a combination of optical retro mode illumination techniques to the imaged one or more amyloid beta plaques and drusen and detecting the imaged one or more amyloid beta plaques and drusen that are too small to be seen with other imaging modalities.
It is an object of the present invention to provide a method for detecting amyloid beta plaques and drusen that may detect relatively smaller amyloid beta plaques than conventional detection methods.
It is an object of the present invention to provide a method for detecting amyloid beta plaques and drusen that may utilize a combination of optical retro mode illumination techniques utilizing a confocal laser scanning ophthalmoscope and one or more super-resolution image processing techniques to detect one or more plaques at an early stage of pathology.
It is an object of the present invention to provide a method for detecting amyloid beta plaques and drusen that detect pathologies such as dry macular degeneration and Alzheimer's disease.
It is an object of the present invention to provide a method for detecting amyloid beta plaques and drusen that tracks changes in a pathology that includes changes in plaque, size, area and density over time.
BRIEF DESCRIPTION OF THE DRAWINGS
The present invention will be described by way of exemplary embodiments, but not limitations, illustrated in the accompanying drawing in which like references denote similar elements, and in which:
FIG. 1 illustrates a flowchart of a first method for detecting amyloid beta plaques and drusen, in accordance with one embodiment of the present invention.
FIG. 2 illustrates a flowchart of a second method for detecting amyloid beta plaques and drusen, in accordance with one embodiment of the present invention.
FIG. 3 illustrates a flowchart of a method for detecting amyloid beta plaques and drusen by a non-transitory computer storage media having instructions stored thereon which, when executed, execute the method, in accordance with one embodiment of the present invention.
DETAILED DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS
Various aspects of the illustrative embodiments will be described using terms commonly employed by those skilled in the art to convey the substance of their work to others skilled in the art. However, it will be apparent to those skilled in the art that the present invention may be practiced with only some of the described aspects. For purposes of explanation, specific numbers, materials and configurations are set forth in order to provide a thorough understanding of the illustrative embodiments. However, it will be apparent to one skilled in the art that the present invention may be practiced without the specific details. In other instances, well-known features are omitted or simplified in order not to obscure the illustrative embodiments. Various operations will be described as multiple discrete operations, in turn, in a manner that is most helpful in understanding the present invention. However, the order of description should not be construed as to imply that these operations are necessarily order dependent. In particular, these
operations need not be performed in the order of presentation.
The phrase "in one embodiment" is used repeatedly. The phrase generally does not refer to the same embodiment, however, it may. The terms "comprising", "having" and "including" are synonymous, unless the context dictates otherwise.
While the present invention has been related in terms of the foregoing embodiments, those skilled in the art will recognize that the invention is not limited to the embodiments described. The present invention may be
practiced with modification and alteration within the spirit and scope of the appended claims. Thus, the description is to be regarded as illustrative instead of restrictive on the present invention.
FIG. 1 illustrates a flowchart of a first method 1 00 for detecting amyloid beta plaques and drusen, in accordance with one embodiment of the present invention.
The overall first method 100 may include means for imaging a plurality of frames of multiple views of a central portion and a peripheral portion of the patient user's retina 1 10, means for aligning and combining the frames utilizing one or more super-resolution techniques 120, means for monitoring the aligned and combined frames 130 and means for quantifying changes in the monitored, aligned and combined frames 140. The means for imaging 1 10 may utilize an optical coherence tomography or OCT imaging technique that is utilized whereby retinal structures may be viewed in cross-section. The means for aligning and combining 120 may utilize a combination of optical retro mode illumination techniques utilizing a confocal laser scanning ophthalmoscope and one or more super-resolution image processing techniques. The means for monitoring the aligned and combined frames 130 may be performed by a non-transitory storage media that receives the retinal structures viewed in cross-section from the optical coherence tomography imaging technique and confocal laser scanning ophthalmoscope and one or more super-resolution image processing techniques. The non-transitory storage media may be executed by a processor and a memory system. The means for quantifying 140 may also be performed by the non-transitory storage media.
FIG. 2 illustrates a flowchart of a second method 200 for detecting amyloid beta plaques and drusen, in accordance with one embodiment of the present invention.
The second method 200 may include the steps of utilizing an annual aperture with a central stop that deviates laterally from a confocal light path 210, blocking directly reflected light from a fundus with only laterally scattered light passing through the annular aperture, thereby imaging the one or more amyloid beta plaques and drusen 220, identifying the imaged one or more amyloid beta plaques and drusen in a retinal structure and a pathology 230, applying a combination of optical retro mode illumination techniques to the imaged one or more amyloid beta plaques and drusen 240 and detecting the imaged one or more amyloid beta plaques and drusen that are too small to be seen with other imaging modalities 250.
The utilizing step 210 may include utilizing an optical coherence
tomography or OCT imaging technique that is utilized whereby retinal structures may be viewed in cross-section. The blocking step 220 may include utilizing an optical coherence tomography or OCT imaging technique that is utilized whereby retinal structures may be viewed in cross-section. The identifying step 230 may include the pathology that is Alzheimer's disease or the pathology that is dry macular degeneration. The applying step 240 may include the optical retro mode illumination techniques that may include a confocal laser scanning
ophthalmoscope and one or more super-resolution image processing techniques. The one or more super-resolution image processing techniques may be multi- image super-resolution image processing techniques. The detecting step 250 may include tracking changes in the pathology over a predetermined period time. The tracking changes may include plaque, size, area and density over the
predetermined period of time.
FIG. 3 illustrates a flowchart of a method 300 for detecting amyloid beta plaques and drusen by a non-transitory computer storage media having instructions stored thereon which, when executed, execute the method 300, in accordance with one embodiment of the present invention.
The non-transitory computer storage media may include the steps of utilizing an annual aperture with a central stop that deviates laterally from a confocal light path 310, blocking directly reflected light from a fundus with only laterally scattered light passing through the annular aperture, thereby imaging the one or more amyloid beta plaques and drusen 320, identifying the imaged one or more amyloid beta plaques and drusen in a retinal structure and a pathology 330, applying a combination of optical retro mode illumination techniques to the imaged one or more amyloid beta plaques and drusen 340 and detecting the imaged one or more amyloid beta plaques and drusen that are too small to be seen with other imaging modalities 350.
The utilizing step 310 may include utilizing an optical coherence
tomography or OCT imaging technique that is utilized whereby retinal structures may be viewed in cross-section. The blocking step 320 may include utilizing an optical coherence tomography or OCT imaging technique that is utilized whereby retinal structures may be viewed in cross-section. The identifying step 330 may include the pathology that is Alzheimer's disease or the pathology that is dry macular degeneration. The applying step 340 may include the optical retro mode illumination techniques that may include a confocal laser scanning
ophthalmoscope and one or more super-resolution image processing techniques. The one or more super-resolution image processing techniques may be multi- image super-resolution image processing techniques. The detecting step 350 may include tracking changes in the pathology over a predetermined period time. The tracking changes may include plaque, size, area and density over the
predetermined period of time.
The method for detecting amyloid beta plaques and drusen may utilize an annular aperture with a central stop that deviates laterally from a confocal light path. Directly reflected light emitted towards a fundus may be blocked by a central stop with only scattered light passing through the annular aperture. Laterally scattered light may be sampled more than light in a direct mode. Retinal structures and pathology may be detected with the only laterally scattered light. Drusen and AB plaques may be imaged with this technique due to increase in scatter. While the method may be helpful in detection of large plaques, the combination of the method with super-resolution and other image processing and analysis techniques may yield a method that may detect relatively much smaller plaques at relatively earlier stages of pathology and may also be tracked over time. Amyloid beta plaque and drusen may be identified in a retinal structure however identification of the deposits at relatively earlier stages of disease and of a relatively small size is impossible with existing retinal imaging technology. This problem may be solved through a combination of optical retro mode illumination techniques utilizing a confocal laser scanning ophthalmoscope in combination with super-resolution image processing techniques that detect relatively very small plaques that are too small to be seen with other imaging modalities. Utilizing retro mode imaging alone does yield some imaging of drusen, AB plaques and other deposits that are relatively small in size but do not reliably image relatively small to very small plaques. Multi-image super-resolution techniques may record a series of images and then combine a data set from the series of images to produce images of relatively greatly improved resolution and image quality thereby resolving the relatively smallest plaques at the relatively earliest stages of disease. Furthermore, tracking changes in plaque, size, area and density over a predetermined period of time is likely an indicator of advancing disease and rate of advancing disease. These aspects have never been previously studied. Multiple images may be acquired utilizing each of the retro-mode
illumination techniques. These images may be transferred to a software or non- transitory storage media to co-registers each of the images. The non-transitory storage media may process the images to increase contrast where intensity shifts occur. The non-transitory storage media may increase a signal by subtracting noise. The subtracted noise may be accomplished by referencing numerous modal images and producing a result where the noise or artifact error from each type of retro mode is removed leaving only the combined signal structures from each retro mode image. The resulting super resolution image may be relatively highly improved over each individual retro mode image and by reducing the signal and building the noise in the individual retro mode image, higher detection sensitivity may be achieved in the final image. A high bit depth final image of approximately eight bits or more may be produced which may be analyzed utilizing conventional methods.
In another embodiment fluorescent emission images may be combined with retro-mode images to produce a co-located detection matrix.
In another embodiment, standard confocal infrared or IR images may be combined with retro-mode images to produce a higher sensitivity traditional confocal image or to produce a hyper-contrast combination image.
In another embodiment, an annual aperture utilized in the retromode may be replaced with a slit, grid, holographic interference image or coded aperture to further increase detection of traditionally sub-resolvable spots.
In another embodiment, multiple focal planes may be acquired and combined, to produce a three-dimensional render of the detected spots. In another embodiment the aperture position may be stepped in the optical path, to alter its interaction with the reflected or emitted light from a subject.
In another embodiment the method may be utilized for a variety of imaging procedures including color fundus imaging, fluorescein angiography, I ndocyanine Green or ICG angiography, red-free, infrared or IR retro-illumination, hyper spectral and multi-spectral imaging, and devices that are utilized in combination with OCT.
The method for detecting amyloid beta plaques and drusen will be utilized for the detection and advancement of dry macular degeneration and
Alzheimer's disease. The method includes imaging a plurality of frames of multiple views of a central portion and a peripheral portion of a patient user's retina, aligning and combining the frames utilizing one or more super-resolution techniques, monitoring the aligned and combined frames and quantifying changes in the monitored, aligned and combined frames. The changes in the aligned and combined frames may be tracked over a predetermined period of time such as a day, a week, a month, a year or other suitable predetermined period of time.

Claims

1 . A method for detecting one or more amyloid beta plaques and drusen in a patient user's retina, comprising:
means for imaging a plurality of frames of multiple views of a central portion and a peripheral portion of the patient user's retina;
means for aligning and combining the frames utilizing one or more super-resolution techniques;
means for monitoring the aligned and combined frames; and means for quantifying changes in the monitored, aligned and combined frames.
2. The method according to claim 1 , wherein the means for imaging utilizes an optical coherence tomography imaging technique.
3. The method according to claim 1 , wherein the means for aligning and combining utilizes a combination of one or more optical retro mode illumination techniques and one or more super-resolution image processing techniques.
4. The method according to claim 3, wherein the combination of one or more optical retro mode illumination techniques and one or more super-resolution image processing techniques utilizes a confocal laser scanning ophthalmoscope.
5. The method according to claim 1 , wherein the means for monitoring and the means for quantifying is performed by a non-transitory storage media, a processor and a memory system.
6. The method according to claim 1 , wherein the method detects Alzheimer's disease and dry macular degeneration.
7. A method for detecting one or more amyloid beta plaques and drusen, comprising the steps of:
utilizing an annular aperture with a central stop that deviates laterally from a confocal light path;
blocking directly reflected light from a fundus with only laterally scattered light passing through the annular aperture, thereby imaging the one or more amyloid beta plaques and drusen;
identifying the imaged one or more amyloid beta plaques and drusen in a retinal structure and pathology;
applying a combination of optical retro mode illumination techniques to the imaged one or more amyloid beta plaques and drusen; and
detecting the imaged one or more amyloid beta plaques and drusen that are too small to be seen with other imaging modalities.
8. The method according to claim 7, wherein the pathology is Alzheimer's disease.
9. The method according to claim 7, wherein the pathology is dry macular degeneration.
10. The method according to claim 7, wherein the optical retro mode
illumination techniques includes a confocal laser scanning ophthalmoscope and one or more super-resolution image processing techniques.
1 1 . The method according to claim 10, wherein the one or more super- resolution image processing techniques are multi-image super-resolution image processing techniques.
12. The method according to claim 7, wherein the method tracks changes in the pathology over a predetermined period time.
13. The method according to claim 12, wherein changes include tracking changes in plaque, size, area and density over the predetermined period of time.
14. A non-transitory computer storage media having instructions stored thereon which, when executed, execute a method comprising the steps of:
utilizing an annual aperture with a central stop that deviates laterally from a confocal light path;
blocking directly reflected light from a fundus with only laterally scattered light passing through the annular aperture, thereby imaging the one or more amyloid beta plaques and drusen;
identifying the imaged one or more amyloid beta plaques and drusen in a retinal structure and pathology;
applying a combination of optical retro mode illumination techniques to the imaged one or more amyloid beta plaques and drusen; and detecting the imaged one or more amyloid beta plaques and drusen that are too small to be seen with other imaging modalities.
15. The non-transitory computer storage media according to claim 14, wherein the pathology is Alzheimer's disease.
16. The non-transitory computer storage media according to claim 14, wherein the pathology is dry macular degeneration.
17. The non-transitory computer storage media according to claim 14, wherein the optical retro mode illumination techniques include a confocal laser scanning ophthalmoscope and one or more super-resolution image processing techniques.
18. The non-transitory computer storage media according to claim 17, wherein the one or more super-resolution image processing techniques are multi-image super-resolution image processing techniques.
19. The non-transitory computer storage media according to claim 14, wherein the method tracks changes in the pathology over a predetermined period time.
20. The non-transitory computer storage media according to claim 19, wherein changes include tracking changes in plaque, size, area and density over the predetermined period of time.
PCT/US2014/026023 2013-03-15 2014-03-13 Method for detecting amyloid beta plaques and drusen WO2014151573A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2016502029A JP2016512712A (en) 2013-03-15 2014-03-13 Method for detecting amyloid beta plaques and drusen
EP14768715.6A EP2967327A4 (en) 2013-03-15 2014-03-13 Method for detecting amyloid beta plaques and drusen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361800882P 2013-03-15 2013-03-15
US61/800,882 2013-03-15

Publications (1)

Publication Number Publication Date
WO2014151573A1 true WO2014151573A1 (en) 2014-09-25

Family

ID=51525856

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2014/026023 WO2014151573A1 (en) 2013-03-15 2014-03-13 Method for detecting amyloid beta plaques and drusen

Country Status (4)

Country Link
US (1) US9566000B2 (en)
EP (1) EP2967327A4 (en)
JP (1) JP2016512712A (en)
WO (1) WO2014151573A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018001838A1 (en) 2016-06-28 2018-01-04 Centervue S.P.A. Ophthalmic machine for acquiring fluorescence images of the retina and related method of use

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2687149A (en) * 1952-03-08 1954-08-24 Thomas & Betts Corp Portable crimping apparatus
EP3922270A1 (en) 2011-12-09 2021-12-15 Regents of the University of Minnesota Hyperspectral imaging for early detection of alzheimer's disease
AU2017229876A1 (en) 2016-03-10 2018-11-01 Regents Of The University Of Minnesota Spectral-spatial imaging device
CN111565624A (en) 2017-11-27 2020-08-21 雷蒂斯派克股份有限公司 Hyperspectral image guided RAMAN ophthalmic imager for Alzheimer's disease pathology

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120229766A1 (en) * 2009-09-30 2012-09-13 Carl Zeiss Meditec Ag Method and device for detecting deposits in the eye
US20120251452A1 (en) * 2011-03-29 2012-10-04 Steven Roger Verdooner Apparatus and method for identifying one or more amyloid beta plaques in a plurality of discrete oct retinal layers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8348429B2 (en) * 2008-03-27 2013-01-08 Doheny Eye Institute Optical coherence tomography device, method, and system
US20110208064A1 (en) * 2008-07-31 2011-08-25 Ran Chongzhao Curcumin Derivatives for Amyloid-Beta Plaque Imaging
JP5474435B2 (en) * 2009-07-30 2014-04-16 株式会社トプコン Fundus analysis apparatus and fundus analysis program
JP5582772B2 (en) * 2009-12-08 2014-09-03 キヤノン株式会社 Image processing apparatus and image processing method
JP5626760B2 (en) * 2010-03-31 2014-11-19 ソニー株式会社 Fluorescent image acquisition method, fluorescent image acquisition program, and fluorescent image acquisition device
EP2566380B1 (en) * 2010-05-05 2020-04-01 Melanie C.W. Campbell Method for imaging amyloid beta in the retina of the eye in association with alzheimer's disease
US9176151B2 (en) * 2010-07-14 2015-11-03 Acumen Pharmaceuticals, Inc. Antibodies, kit and method for detecting amyloid beta oligomers
CN103188988A (en) * 2010-08-27 2013-07-03 索尼公司 Image processing apparatus and method
JP5693101B2 (en) * 2010-08-30 2015-04-01 キヤノン株式会社 Image processing apparatus and image processing method
WO2012061078A2 (en) * 2010-10-25 2012-05-10 Steven Verdooner Apparatus and method for detecting amyloid in a retina in a diagnosis, advancement, and prognosing of alzheimer's disease, traumatic brain injury, macular degeneration and a plurality of neurodegenerative dissorders, and ocular diseases
EP2641211A1 (en) * 2010-11-17 2013-09-25 Optovue, Inc. 3d retinal disruptions detection using optical coherence tomography
JP5948757B2 (en) * 2011-08-08 2016-07-06 株式会社ニデック Fundus photographing device
JP2015080679A (en) * 2013-10-24 2015-04-27 キヤノン株式会社 Image processing system, image processing method, and program

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120229766A1 (en) * 2009-09-30 2012-09-13 Carl Zeiss Meditec Ag Method and device for detecting deposits in the eye
US20120251452A1 (en) * 2011-03-29 2012-10-04 Steven Roger Verdooner Apparatus and method for identifying one or more amyloid beta plaques in a plurality of discrete oct retinal layers

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
JENNIFER H. ACTON ET AL.: "Drusen detection in retro-mode imaging by a scanning laser ophthalmoscope.", ACTA OPHTHALMOLOGICA, vol. 89, 2011, pages E.404 - E411, XP055284351 *
ROBINSON M. DIRK ET AL., NEW APPLICATIONS OF SUPER-RESOLUTION IN MEDICAL IMAGING., 2010, pages 15 - 21, XP055284350 *
See also references of EP2967327A4 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018001838A1 (en) 2016-06-28 2018-01-04 Centervue S.P.A. Ophthalmic machine for acquiring fluorescence images of the retina and related method of use

Also Published As

Publication number Publication date
EP2967327A4 (en) 2017-03-22
US9566000B2 (en) 2017-02-14
EP2967327A1 (en) 2016-01-20
US20140268052A1 (en) 2014-09-18
JP2016512712A (en) 2016-05-09

Similar Documents

Publication Publication Date Title
US10039487B2 (en) Method for detecting a disease by analysis of retinal vasculature
Kurokawa et al. Adaptive optics optical coherence tomography angiography for morphometric analysis of choriocapillaris
Chen et al. Peripapillary retinal nerve fiber layer vascular microcirculation in glaucoma using optical coherence tomography–based microangiography
Zhang et al. Ultra-wide optical coherence tomography angiography in diabetic retinopathy
Bernardes et al. Digital ocular fundus imaging: a review
US20170319061A1 (en) Volume analysis and display of information in optical coherence tomography angiography
US20140268052A1 (en) Method for detecting amyloid beta plaques and drusen
US9839351B2 (en) Image generating apparatus, image generating method, and program
US10383516B2 (en) Image generation method, image generation apparatus, and storage medium
US20160278627A1 (en) Optical coherence tomography angiography methods
US11887288B2 (en) Image processing apparatus, image processing method, and storage medium
US10856735B2 (en) Optical coherence tomography (OCT) system with improved image quality
Alten et al. Signal reduction in choriocapillaris and segmentation errors in spectral domain OCT angiography caused by soft drusen
US20140320820A1 (en) Method and device for monitoring retinopathy
Baran et al. Tail artifact removal in OCT angiography images of rodent cortex
US9854963B2 (en) Apparatus and method for identifying one or more amyloid beta plaques in a plurality of discrete OCT retinal layers
Liu et al. Whole‐brain microcirculation detection after ischemic stroke based on swept‐source optical coherence tomography
US10980411B2 (en) Information processing apparatus, information processing method, and storage medium
Tang et al. Imaging amyloid and tau in the retina: current research and future directions
Rapolu et al. Enhancing microvasculature maps for Optical Coherence Tomography Angiography (OCT-A)
US20240016380A1 (en) Method of detecting one or more change in an eye and disease indication or diagnosis
US20230072066A1 (en) Choroidal Imaging
AbdelAl et al. “For Mass Eye and Ear Special Issue” Adaptive Optics in the Evaluation of Diabetic Retinopathy
Houston The retinal microvasculature in secondary progressive multiple sclerosis
Wang et al. Optical Coherence Tomography Angiography: Optical Microangiography

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14768715

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2016502029

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2014768715

Country of ref document: EP